IRIS PubliCatt

D'Amico, Adele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.673
NA - Nord America 1.635
AS - Asia 358
SA - Sud America 15
AF - Africa 9
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.695
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.620
DE - Germania 566
SE - Svezia 323
IT - Italia 220
CN - Cina 186
IE - Irlanda 163
UA - Ucraina 103
FR - Francia 82
SG - Singapore 73
GB - Regno Unito 65
RU - Federazione Russa 44
IN - India 41
FI - Finlandia 38
TR - Turchia 21
IR - Iran 15
NL - Olanda 15
BE - Belgio 13
CA - Canada 9
CH - Svizzera 9
BR - Brasile 7
CZ - Repubblica Ceca 7
JP - Giappone 7
PL - Polonia 7
CI - Costa d'Avorio 6
PA - Panama 5
AR - Argentina 4
ES - Italia 3
KR - Corea 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DK - Danimarca 2
EG - Egitto 2
HK - Hong Kong 2
HU - Ungheria 2
IL - Israele 2
TW - Taiwan 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.695
Salva come PNG Salva come JPEG
Città #
Chandler 382
Ashburn 157
Dublin 149
New York 108
San Mateo 72
Jacksonville 58
Wilmington 49
Houston 48
Milan 46
Boston 45
Singapore 45
Nanjing 42
Moscow 40
Nürnberg 40
Rome 37
Marseille 33
Bremen 30
Princeton 30
Woodbridge 29
Ann Arbor 28
Dearborn 26
Lawrence 23
Munich 22
Beijing 18
Fairfield 18
Lancaster 16
Hebei 15
Helsinki 15
Izmir 15
Redwood City 15
Nanchang 14
Seattle 14
Cattolica 13
Inverigo 13
Changsha 12
Los Angeles 12
Boardman 11
Norwalk 10
Washington 10
Detroit 9
Leawood 9
Cambridge 8
Kish 8
Shenyang 8
University Park 8
Brussels 7
Jinan 7
Menlo Park 7
Mountain View 7
Zhengzhou 7
Abidjan 6
Andover 6
Augusta 6
Chicago 6
Jiaxing 6
Palermo 6
Redmond 6
Rignano Flaminio 6
Shanghai 6
Tianjin 6
Angri 5
Brno 5
Pune 5
San Diego 5
Toronto 5
Bern 4
Buenos Aires 4
Hangzhou 4
Kiel 4
Monza 4
Ningbo 4
San Jose 4
Taizhou 4
Bitonto 3
Changchun 3
Clearwater 3
Grottaferrata 3
Guangzhou 3
Istanbul 3
Kunming 3
Lima 3
Liège 3
London 3
Naaldwijk 3
Neded 3
Québec 3
San Francisco 3
Seoul 3
São Paulo 3
Trieste 3
Turin 3
Amsterdam 2
Ardabil 2
Bari 2
Bengaluru 2
Cairo 2
Drzewica 2
Florence 2
Frankfurt am Main 2
Fremont 2
Totale 2.034
Salva come PNG Salva come JPEG
Nome #
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 253
Spinal muscular atrophy 184
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 121
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 115
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 95
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 91
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 91
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 91
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 87
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 86
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 84
The empowerment of translational research: lessons from laminopathies 81
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 77
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 74
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 72
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 69
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 68
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 66
Histological effects of givinostat in boys with Duchenne muscular dystrophy 65
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 63
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 63
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 62
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 62
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita 60
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 60
Outcome of fetuses with congenital cytomegalovirus infection: a systematic review and meta-analysis 59
Longitudinal natural history in young boys with Duchenne muscular dystrophy 57
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 57
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 56
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients 56
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 55
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 55
MRI in sarcoglycanopathies: a large international cohort study 52
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. 52
Healthy design and urban planning strategies, actions, and policy to achieve salutogenic cities 52
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 50
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 50
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 50
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 49
The genetic basis of undiagnosed muscular dystrophies and myopathies 48
Clinical Variability in Spinal Muscular Atrophy Type III. 47
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 47
Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies 46
Development of an academic disease registry for spinal muscular atrophy 45
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 44
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 43
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study 43
Type I Spinal Muscular Atrophy patients treated with nusinersen: 4 year follow-up of motor, respiratory and bulbar function 41
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 40
Gain and loss of abilities in type II SMA: A 12-month natural history study 39
MRI in sarcoglycanopathies: A large international cohort study 36
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 23
Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study 22
“Art, Colors, and Emotions” Treatment (ACE-t): A Pilot Study on the Efficacy of an Art-Based Intervention for People With Alzheimer’s Disease 22
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 21
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 21
Developmental lag of visuospatial attention in Duchenne muscular dystrophy 20
Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. 19
Long term follow-up of scoliosis progression in type II SMA patients 18
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 17
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 17
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 16
Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa 16
A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy 11
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy 11
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 9
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 7
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 5
Totale 3.784
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 15 20 13 18 32 52 7 14 19 58 23
2020/2021253 2 23 5 17 21 19 43 8 36 14 63 2
2021/2022526 32 17 9 46 27 26 9 77 37 39 109 98
2022/20231.142 124 149 70 188 78 140 72 90 123 24 56 28
2023/2024761 33 178 38 53 34 152 49 39 19 24 65 77
2024/202544 35 9 0 0 0 0 0 0 0 0 0 0
Totale 3.784